HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ningning Liu Selected Research

licoisoflavone A

3/2020High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ningning Liu Research Topics

Disease

43Neoplasms (Cancer)
06/2022 - 01/2011
11Infections
11/2021 - 12/2013
9Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 10/2014
7Inflammation (Inflammations)
07/2022 - 05/2011
7Neoplasm Metastasis (Metastasis)
06/2022 - 01/2016
7Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2012
6Breast Neoplasms (Breast Cancer)
01/2020 - 03/2016
5Carcinogenesis
12/2021 - 10/2014
5Stomach Neoplasms (Stomach Cancer)
12/2021 - 06/2009
5Hypoxia (Hypoxemia)
09/2021 - 01/2013
5Hypertrophy
01/2021 - 01/2016
4Fibrosis (Cirrhosis)
01/2021 - 01/2013
4Atherosclerosis
11/2020 - 01/2020
4Cardiomegaly (Heart Hypertrophy)
03/2020 - 01/2013
4Prostatic Neoplasms (Prostate Cancer)
03/2019 - 01/2017
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2019 - 01/2014
3Rheumatic Fever (Acute Articular Rheumatism)
01/2018 - 07/2014
3Multiple Myeloma
02/2017 - 06/2014
2Myocardial Infarction
09/2021 - 11/2019
2Ischemia
12/2020 - 01/2014
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 01/2020
2Hyperplasia
01/2019 - 01/2017
2Body Weight (Weight, Body)
12/2018 - 01/2013
2Rheumatoid Arthritis
08/2018 - 01/2016
2Leukemia
09/2016 - 02/2011
1Parkinson Disease (Parkinson's Disease)
07/2022
1Myocardial Ischemia (Ischemic Heart Diseases)
06/2022
1Reperfusion Injury
06/2022

Drug/Important Bio-Agent (IBA)

27Proteasome Endopeptidase Complex (Proteasome)IBA
06/2022 - 01/2011
19Deubiquitinating EnzymesIBA
11/2021 - 06/2014
14Proteins (Proteins, Gene)FDA Link
09/2021 - 06/2009
8Ubiquitin-Specific ProteasesIBA
06/2022 - 01/2016
7UbiquitinIBA
10/2021 - 06/2014
7Bortezomib (Velcade)FDA Link
09/2018 - 01/2012
7gambogic acidIBA
04/2015 - 02/2011
6Therapeutic UsesIBA
06/2022 - 09/2016
6MicroRNAs (MicroRNA)IBA
01/2022 - 12/2013
6Pharmaceutical PreparationsIBA
03/2020 - 12/2013
6Auranofin (Ridaura)FDA Link
03/2019 - 07/2014
6Proteasome InhibitorsIBA
09/2016 - 02/2011
5CaspasesIBA
09/2017 - 01/2014
4Oxygen (Dioxygen)IBA
06/2022 - 01/2014
4Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022 - 04/2014
4GoldIBA
04/2022 - 07/2014
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 10/2014
4Androgen Receptors (Androgen Receptor)IBA
03/2019 - 01/2017
3Biological ProductsIBA
01/2020 - 02/2011
3Estrogen ReceptorsIBA
01/2020 - 01/2018
3Biomarkers (Surrogate Marker)IBA
08/2018 - 06/2014
3Peptide Hydrolases (Proteases)FDA Link
04/2017 - 06/2014
3Antineoplastic Agents (Antineoplastics)IBA
02/2017 - 02/2011
3Transcription Factors (Transcription Factor)IBA
12/2016 - 01/2014
3Messenger RNA (mRNA)IBA
12/2013 - 01/2012
2IntegrinsIBA
06/2022 - 01/2020
2Long Noncoding RNAIBA
12/2021 - 12/2019
2LipopolysaccharidesIBA
10/2021 - 11/2019
2Oncogene Proteins (Oncogene Protein)IBA
10/2021 - 01/2017
2Bevacizumab (Avastin)FDA Link
01/2021 - 01/2020
2Adenosine Triphosphate (ATP)IBA
01/2021 - 01/2012
2CateninsIBA
01/2021 - 01/2020
2Cetuximab (Erbitux)FDA Link
01/2021 - 01/2020
2p38 Mitogen-Activated Protein KinasesIBA
12/2020 - 10/2014
2CD36 AntigensIBA
11/2020 - 01/2020
2Angiotensin IIIBA
03/2020 - 01/2016
2Isoproterenol (Isoprenaline)FDA LinkGeneric
03/2020 - 01/2013
2CytokinesIBA
01/2020 - 01/2017
2tanshinoneIBA
01/2020 - 01/2020
2TamoxifenFDA LinkGeneric
01/2020 - 03/2017
2bcr-abl Fusion ProteinsIBA
01/2019 - 01/2014
2EnzymesIBA
01/2018 - 01/2018
2AndrogensIBA
09/2017 - 01/2017
2benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
09/2017 - 01/2016
2Acetylcysteine (Siran)FDA LinkGeneric
09/2017 - 04/2014
2Platinum Compounds (Compounds, Platinum)IBA
01/2017 - 09/2016
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 09/2016
2Ubiquitinated ProteinsIBA
01/2017 - 01/2011
2PlatinumIBA
01/2017 - 09/2016
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2017 - 04/2015
2ChromatinIBA
01/2017 - 01/2012
2platinum pyrithioneIBA
01/2017 - 09/2016
2ATP dependent 26S protease (26S proteasome)IBA
09/2016 - 01/2011
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2016 - 03/2015
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2016 - 06/2009
2CopperIBA
01/2015 - 06/2014
2SurvivinIBA
01/2015 - 01/2014
2Retinaldehyde (Retinal)IBA
01/2015 - 01/2014
2Antirheumatic Agents (DMARD)IBA
10/2014 - 07/2014
2Imatinib Mesylate (Gleevec)FDA Link
10/2014 - 01/2014
2Histones (Histone)IBA
01/2012 - 01/2012
2Histone Deacetylase InhibitorsIBA
01/2012 - 01/2012
2Carnitine (L-Carnitine)FDA LinkGeneric
01/2012 - 01/2012
1SynucleinsIBA
07/2022
1Cholecystokinin (Pancreozymin)IBA
07/2022
1Glucagon-Like Peptide 1 (GLP 1)IBA
07/2022
1LiraglutideFDA Link
07/2022
1Free RadicalsIBA
06/2022

Therapy/Procedure

23Therapeutics
06/2022 - 02/2011
6Drug Therapy (Chemotherapy)
03/2021 - 12/2013
3Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 01/2020
2Ligation
11/2021 - 01/2019